CHK-336
Product Specifications
UNSPSC Description
CHK-336 (Example 1) is an orally active LDHA inhibitor (IC50[1].
Target Antigen
Lactate Dehydrogenase
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Applications
Metabolism-sugar/lipid metabolism
Field of Research
Metabolic Disease
Assay Protocol
https://www.medchemexpress.com/chk-336.html
Solubility
DMSO : ≥ 130 mg/mL
Smiles
O=C(C1=CSC(N2N=C(C(CC3=CC=C(S(=O)(N)=O)C(F)=C3)=C2CC4CC4)C5=CC=C(F)C=C5)=N1)O
Molecular Weight
530.57
References & Citations
[1]David Andrew Powell, et al. Substituted pyrazolyl compounds and methods of use thereof. Patent WO2021234547A1.
Shipping Conditions
Room Temperature
Product Datasheet
http://file.medchemexpress.com/batch_PDF/HY-156683/CHK-336-DataSheet-MedChemExpress.pdf
Product MSDS
http://file.medchemexpress.com/batch_PDF/HY-156683/CHK-336-SDS-MedChemExpress.pdf
Clinical Information
Phase 1
CAS Number
2743436-86-2
Available Sizes
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
